Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.
about
Protein microarrays discover angiotensinogen and PRKRIP1 as novel targets for autoantibodies in chronic renal diseaseBiomarkers of Renal Disease and Progression in Patients with DiabetesAdvances in the use of multimarker panels for renal risk stratificationMeasurement of renal function in patients with chronic kidney diseaseBiomarkers in nephrology: Core Curriculum 2013Therapeutic modalities in diabetic nephropathy: standard and emerging approaches.Biomarkers in chronic kidney disease, from kidney function to kidney damagePlasma neutrophil gelatinase-associated lipocalin in acute kidney injury superimposed on chronic kidney disease after cardiac surgery: a multicenter prospective studyTherapeutic Modalities in Diabetic Nephropathy: Future Approaches.Paediatric normative data for urine NGAL/creatinine ratio.Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study.First evidence of subclinical renal tubular injury during sickle-cell crisis.Screening for chronic kidney disease in HIV-infected patients.Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance.Folate receptor alpha, mesothelin and megakaryocyte potentiating factor as potential serum markers of chronic kidney disease.Renal recoveryEffect of glomerular filtration rate impairment on diagnostic performance of neutrophil gelatinase-associated lipocalin and B-type natriuretic peptide as markers of acute cardiac and renal failure in chronic kidney disease patients.Association of urinary injury biomarkers with mortality and cardiovascular events.Concomitant elevations of MMP-9, NGAL, proMMP-9/NGAL and neutrophil elastase in serum of smokers with chronic obstructive pulmonary disease.Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury.Early detection and intervention using neutrophil gelatinase-associated lipocalin (NGAL) may improve renal outcome of acute contrast media induced nephropathy: a randomized controlled trial in patients undergoing intra-arterial angiography (ANTI-CINThe use of targeted biomarkers for chronic kidney disease.Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.Urinary Neutrophil Gelatinase-Associated Lipocalin predicts the severity of contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary proceduresAssociation between plasma neutrophil gelatinase associated lipocalin level and obstructive sleep apnea or nocturnal intermittent hypoxiaAssociation of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitusCKD273, a new proteomics classifier assessing CKD and its prognosisGreen tea polyphenols stimulate mitochondrial biogenesis and improve renal function after chronic cyclosporin a treatment in ratsLipocalin-2 expressed in innate immune cells is an endogenous inhibitor of inflammation in murine nephrotoxic serum nephritis.NGAL distinguishes steroid sensitivity in idiopathic nephrotic syndromeRenal dysfunction is a stronger determinant of systemic neutrophil gelatinase-associated lipocalin levels than myocardial dysfunction in systolic heart failureUrinary biomarkers track the progression of nephropathy in hypertensive and obese rats.Normalisation of urinary biomarkers to creatinine for clinical practice and research--when and why.Urinary NGAL is a useful clinical biomarker of HIV-associated nephropathy.Preliminary study of Huai Qi Huang granules delay the development of primary glomerular diseases in human.Urinary biomarkers at early ADPKD disease stageComparative assessment of neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C as early biomarkers for early detection of renal failure in patients with hypertensionPlasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy.High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.Effect of Omega-3 Fatty Acid on the Fatty Acid Content of the Erythrocyte Membrane and Proteinuria in Patients with Diabetic Nephropathy.
P2860
Q24320230-A77C125C-F357-4B72-8C8C-ACAB977F851EQ26799505-6D5AC863-0015-46C3-AA83-9D3EDDD54A72Q26853272-36608478-3ED7-4293-8243-CE732E6F7A3BQ26853698-4C08965E-025D-4F0F-810E-EB691D12DCC2Q26861451-AA6C0155-15EE-4FAB-9A4C-F4A1E43B9267Q27007027-C7C536D3-7509-4F49-9840-0DE720B7B9D7Q28087304-4D4C7D1A-F756-4BE0-96A0-2E9C4ED35FB9Q30391513-6DA6526A-0D6A-4841-95FE-F6CD95621B2EQ30423005-DBA0CDD5-D644-49AF-9585-5AF6F7A4FF99Q30590366-4DE55E51-02C5-4FF8-A26E-7C5A3901E348Q30879334-6389F1B7-B875-4DA6-9BAB-EEB0612235A9Q33553300-F59B59C6-6071-484A-BA10-F282F202E664Q33639802-A4837945-E63F-4C7F-9870-CB917012C2C1Q33684220-BB0F9595-D8F0-4C5C-839C-1A319B254946Q33734661-F55782DE-7662-4EBB-A930-A253C0724F46Q33750273-00CA30C5-EF51-43E4-9844-6A4C0D5C7B30Q33754152-24184B99-F8CE-4791-BE52-86185A8BB7EFQ33814882-A29672E7-06E6-4505-B26D-5B310B3DFA47Q33844617-53B7C208-F0DA-4EA4-986C-EEE1E03651B7Q33945154-79C7BE26-5EA1-4986-8669-36B20D0DCAB6Q33995274-4CD7A90A-2691-4362-8C33-76296AA9238DQ34346928-5A10C4F8-0E2C-4859-9E97-47E05309BD45Q34501874-34C9A38F-394E-48A7-A5DE-BD5A1C3B45ABQ34523585-FAD7AF57-239B-4B02-8091-568C0753EC89Q34559205-7962E0D2-4C57-4DDB-A84A-ACD8BD2DD5BEQ34644160-1F40FE1D-8B9C-42BB-8390-96B6CE1FAF62Q34729912-F3B8308F-E720-4296-BC5D-8399BAF73FB4Q34766031-965E862D-7516-4AC5-A0B2-6B0DCBB924A6Q34825843-B17E8D0E-F57B-40F5-B4E9-F769A31827E7Q34997491-2402DF31-1B59-4B2E-9207-DB67A333AB6CQ35017352-88BCF773-58AA-4C10-AA0A-5484DC06FEA3Q35064410-F52F6012-B837-481D-8CD7-C92C82DE5259Q35076289-B31A4583-3B03-4751-9797-866F3A455F4DQ35188531-4F100978-60DE-47EB-AC88-12C2046E296AQ35269939-9F1E3AA1-FECF-427C-9D49-D570E99779DCQ35392624-B6E46A6E-311B-4EAF-8C19-ADD12D56EED7Q35547961-870FCE59-321A-4444-91EA-B9F3B11C25D1Q35626252-614EAE9A-32C1-44F8-8B55-11D72190B988Q35626257-979AE579-AA58-4601-89CF-F242A19DF6F7Q35674267-9B8321A3-4378-4476-8A38-17307813438D
P2860
Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neutrophil gelatinase-associat ...... ion of chronic kidney disease.
@en
type
label
Neutrophil gelatinase-associat ...... ion of chronic kidney disease.
@en
prefLabel
Neutrophil gelatinase-associat ...... ion of chronic kidney disease.
@en
P2093
P2860
P50
P356
P1476
Neutrophil gelatinase-associat ...... sion of chronic kidney disease
@en
P2093
Giacomo Nicocia
Maria Rosaria Fazio
Michele Buemi
Susanna Campo
Valentina Donato
P2860
P304
P356
10.2215/CJN.03530708
P577
2009-01-28T00:00:00Z